Preclinical efficacy of tasquinimod in myelodysplastic neoplasms: Restoring erythropoiesis and mitigating bone loss
Abstract Myelodysplastic neoplasms (MDSs) are clonal disorders characterized by ineffective hematopoiesis, dysplasia, and a risk of transformation into acute myeloid leukemia. MDS is also associated with a higher incidence of osteoporosis, suggesting a complex interplay between hematopoiesis, the bo...
Збережено в:
| Автори: | , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wiley
2026-04-01
|
| Серія: | HemaSphere |
| Онлайн доступ: | https://doi.org/10.1002/hem3.70352 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|